Prodromal multiple sclerosis: considerations and future utility

Katharine E Harding1, Karim L Kreft2, Yoav Ben-Shlomo3

  • 1Department of Neurology, Aneurin Bevan University Health Board, Royal Gwent Hospital, Cardiff Road, Newport, NP20 2UB, UK. katharineharding@doctors.org.uk.

Journal of Neurology
|February 11, 2024
PubMed
Summary

A multiple sclerosis (MS) prodrome, characterized by increased healthcare use and specific symptoms before diagnosis, offers potential for early intervention and disease management. Further research is needed to answer key questions about its length and symptom specificity.